CORRECTION article

Front. Pharmacol., 09 January 2024

Sec. Pharmacology of Anti-Cancer Drugs

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1322332

Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo

  • 1. Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth University (Deemed to-be University), Puducherry, India

  • 2. Department of Pathology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth University (Deemed to-be University), Puducherry, India

  • 3. Department of Pharmacy, National University of Singapore, Singapore, Singapore

  • 4. Department of Visual Neurosciences, Singapore Eye Research Institute, Singapore, Singapore

  • 5. Eye-APC, Duke-NUS Medical School, Singapore, Singapore

  • 6. Department of General Paediatrics, Haematology/Oncology, University Children’s Hospital Tübingen, Tübingen, Germany

  • 7. ScirosBio (FZC), SRTI Park, Sharjah, United Arab Emirates

  • 8. Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India

  • 9. Department of Ageing Research, Manipal School of Life Sciences, MAHE, Manipal, Karnataka, India

Article metrics

View details

1,3k

Views

595

Downloads

In the published article, there was an error in Table 1. The values of drug doses were inadvertently misrepresented during the final assembly of Table 1. The corrected Table 1 and its caption appear below.

TABLE 1

GroupsDrugsDosage (mg/kg body weight)
Group IITumor controlNA
Group IIIT50
Group IVM80
Group VE150
Group VITM50 + 80
Group VIITE50 + 150
Group VIIIME80 + 150
Group IXTME50 + 80 + 150

The concentration of each drug used in the treatment of animals both individually and in combination.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

glioma, metformin, epigallocatechin gallate (EGCG), molecular docking, quantum mechanics (QM), ROS-reactive oxygen species, PI3K/Akt/mTOR pathway

Citation

Kuduvalli SS, Daisy PS, Vaithy A, Purushothaman M, Muralidharan AR, Agiesh KB, Mezger M, Antony JS, Subramani M, Dubashi B, Biswas I, Guruprasad KP and Anitha TS (2024) Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo. Front. Pharmacol. 14:1322332. doi: 10.3389/fphar.2023.1322332

Received

16 October 2023

Accepted

22 December 2023

Published

09 January 2024

Volume

14 - 2023

Edited by

Jianqiang Xu, Dalian University of Technology, China

Reviewed by

Chandrabose Selvaraj, Alagappa University, India

Updates

Copyright

*Correspondence: T. S. Anitha,

† Present address: T. S. Anitha, Department of Biochemistry and Molecular Biology, Pondicherry University, Puducherry, India

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics